Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo

This publication has 43 references indexed in Scilit:

• Silencing Primary Dystonia: Lentiviral-Mediated RNA Interference Therapy for DYT1 Dystonia
  Journal of Neuroscience, 2005
• RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model
  Proceedings of the National Academy of Sciences, 2005
• CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life
  Oncogene, 2004
• siRNA relieves chronic neuropathic pain
  Nucleic Acids Research, 2004
• Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis
  Aging Cell, 2003
• ALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes
  BMC Neuroscience, 2003
• Induction of an interferon response by RNAi vectors in mammalian cells
  Nature Genetics, 2003
• In vitro photochemical cataract in mice lacking copper-zinc superoxide dismutase
  Free Radical Biology & Medicine, 2001
• Hindlimb Motor Neurons Require Cu/Zn Superoxide Dismutase for Maintenance of Neuromuscular Junctions
  The American Journal of Pathology, 1999
• Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS)
  Brain Research, 1995